Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | HALEOSLABS HALEOS LABS LIMITED Pharma · Small | BAFNAPH Bafna Pharmaceuticals Limited Pharma · Small | MEDICAMEQ Medicamen Biotech Limited Pharma · Small | AMANTA Amanta Healthcare Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 29 | 24 | 19 | 44 |
| Verdict | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Style | OVERVALUED | OVERVALUED | OVERVALUED | WATCHLIST |
| Piotroski | 8/9 | 2/9 | 5/9 | 6/9 |
| Valuation | 7/30 | 5/30 | 4/30 | 9/30 |
| Growth | 8/25 | 9/25 | 5/25 | 21/25 |
| Quality | 0/20 | 0/20 | 0/20 | 0/20 |
| Balance Sheet | 9/15 | 11/15 | 9/15 | 7/15 |
| Cash Flow | 3/10 | 3/10 | 0/10 | 4/10 |
| Price | ₹1,407.9 | ₹174.58 | ₹239.75 | ₹135.46 |
| P/E | 23.70 | — | 31.40 | 31.80 |
| P/B | 1.92 | 0.90 | 1.10 | 2.38 |
| ROE | 8.44% | -6.18% | 3.95% | 10.40% |
| ROCE | 9.91% | -3.00% | 5.43% | 11.60% |
| Debt / Equity | 0.52 | 0.06 | 0.17 | 1.11 |
| FCF Yield | — | — | — | — |
| Dividend Y | 0.11% | — | 0.45% | — |
| Altman Z | 2.91 | 7.86 | 3.86 | 2.40 |
| Promoter % | 72.10% | 75.00% | 40.46% | 63.72% |
| Mkt Cap (₹Cr) | 410.00 | 459.00 | 303.00 | 523.00 |
| Graham # | ₹953.72 | — | ₹180.21 | ₹69.9 |
| Fair PE | 13.8 | 42.0 | 5.8 | 42.0 |
| MoS % | -77.9% | — | -483.4% | +15.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startHALEOSLABS101
BAFNAPH212
MEDICAMEQ47
AMANTA97